Biofrontera Inc. Closes Purchase of All Ameluz® and RhodoLED® US Assets from Biofrontera AG
Biofrontera Inc. acquires full U.S. rights to Ameluz® and RhodoLED®, including New Drug Application and associated patents, from former parent...
Year: 2025
MAIA Biotechnology Details 30-Month Patient Survival in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer
Outstanding measure of efficacy relative to high-risk cancers with limited treatment options CHICAGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- MAIA...
CorMedix Inc. Receives Innovative Technology Designation From Vizient for DefenCath
BERKELEY HEIGHTS, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...
Izotropic CEO Interview: IzoView Differentiators, Regulatory Plans, and Outlook
Vancouver, British Columbia, and Sacramento, California--(Newsfile Corp. - October 23, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3)...
BioNxt Enters the Final Stretch Before Human Trials for Next-Generation MS Drug
NEW YORK, Oct. 23, 2025 /PRNewswire/ -- BioNxt Solutions Inc. (CSE:BNXT) (OTCQB:BNXTF) (FSE:BXT), a bioscience company developing next-generation drug delivery...
Vitrolife AB (publ) – Interim report Q3, 2025: Strong growth in Americas
GOTHENBURG, Sweden, Oct. 23, 2025 /PRNewswire/ -- Third quarter Sales of SEK 835 (867) million, 3% growth in local currencies...
LICORbio Strengthens Global Research Engagement With Bioz Prime Badges and Bioz Content Hub
PALO ALTO, CA / ACCESS Newswire / October 23, 2025 / Bioz, Inc., the industry-standard AI citation solution built to...
Defence to Present New Scientific Data on Its ADC-Enhancing Accum Technology at the World ADC Conference in San Diego, USA, November 4-5, 2025
Montreal, Quebec--(Newsfile Corp. - October 23, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the...
MGI Tech partners with Eva Holding Group to enhance the accuracy of disease monitoring
SÃO PAULO, Oct. 22, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company dedicated to developing essential tools and technologies...
Dover, Delaware — Expert Systems Inc., a leading life sciences accelerator, Supports Traws Pharma Phase 2 Clinical Studies of Ratutrelvir — a Novel Ritonavir-Free Antiviral for COVID-19.
DOVER, Del., Oct. 22, 2025 /PRNewswire/ -- Expert Systems Inc., a leading life sciences accelerator, announced its continued support for...
Did DEA’s Anne Milgram Get Caught in Her Own Marijuana Criminal Algorithms?
"The ex-New Jersey Attorney General and former DEA Administrator promised to modernize justice through data. Instead, under her watch, illegal...
CORRECTION: MDaudit Spotlights the Vital Role of Health Information Professionals in Today’s Evolving Healthcare Landscape
The following is a corrected version of the Oct. 21, 2025, press release, MDaudit Spotlights the Vital Role of Health...
Lam Research Corporation Reports Financial Results for the Quarter Ended September 28, 2025
FREMONT, Calif., Oct. 22, 2025 /PRNewswire/ -- Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for...
Jeffrey Modell Foundation Launches Global Speaker Series
Uniting the global PI community to accelerate early diagnosis, education, and collaboration — with CME credit through Columbia University. NEW...
Lightfully Behavioral Health Expands Access to Specialized Schizoaffective Disorder Treatment Across Full Continuum of Care
THOUSAND OAKS, Calif., Oct. 22, 2025 /PRNewswire/ -- Lightfully Behavioral Health has announced the expansion of its clinical services to...
NEUROMARK® Now with Expanded Access on UnitedHealthcare’s Medicare Advantage Policy for Posterior Nasal Nerve Ablation
Effective immediately, CPT 31242 is no longer considered experimental, removing a key barrier for ENT physicians treating chronic rhinitis. GALWAY, Ireland, Oct....
Moberg Analytics Secures $600,000 to Accelerate Commercialization of Its Brain Monitoring Platform
PHILADELPHIA, Oct. 22, 2025 /PRNewswire/ -- Moberg Analytics, a pioneer in advanced brain monitoring and critical care informatics, today announced...
3 in 5 HIM Leaders Report No FY26 Budget Set for TEFCA Onboarding Even as EHR Vendors Light Up National Exchange
Based on a Black Book Research flash survey of 97 HIM leaders conducted at AHIMA 2025 last week. MINNEAPOLIS, MN...
Epica International Appoints Alok K. Agrawal to Its Board of Directors
Seasoned technology and venture executive join to support Epica's continued global growth and innovation strategy. LANDRUM, SC / ACCESS Newswire...
Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint
Company to discontinue development of mRNA-1647 in congenital CMVCompany will continue to evaluate mRNA-1647 in ongoing Phase 2 trial in...